Biopharmaceutical Excipients Market to Reach USD 4.04 Billion by 2032, Driven by Growing Demand …
The increasing adoption of biologics, including monoclonal antibodies and gene therapies, is propelling the growth of the biopharmaceutical excipients market.
According to SNS Insider Research, The Biopharmaceutical Excipients Market was valued at USD 2.57 billion in 2023 and is anticipated to grow to USD 4.04 billion by 2032, at a CAGR of 5.18% during the forecast period 2024-2032.